Hormone-induced apoptosis by Fas-nuclear receptor fusion proteins: Novel biological tools for controlling apoptosis in vivo

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4164-4170

  Takebayashi, Hirohide ^a   Oida, Hiroji ^a,b   Fujisawa, Kazuko ^a   Yamaguchi, Masahiro ^a   Hikida, Takatoshi ^a   Fukumoto, Manabu ^a   Narumiya, Shuh ^a   Kakizuka, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; FAS ANTIGEN; HYBRID PROTEIN; RECEPTOR PROTEIN; RETINOIC ACID RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; FIBROSARCOMA; GENE THERAPY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL LINE; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; ESTRADIOL; ESTRIOL; FEMALE; FIBROSARCOMA; HELA CELLS; HUMANS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; SEQUENCE TAGGED SITES; TAMOXIFEN; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0029810082     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Mattioni, T., Louvion, J-F., and Picard, D. Regulation of protein activities by fusion to steroid binding domains. Methods Cell Biol , 43: 335-352, 1994
2. Eilers, M., Picard, D., Yamamoto, K. R., and Bishop, J. M. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (Lond.), 340: 66-68, 1989.
3. Burk, O., and Klempnauer, K-H. Estrogen-dependent alterations in differentiation state of myeloid cells caused by a v-myb/estrogen receptor fusion protein. EMBO J., 10 3713-3719, 1991.
4. Boehmelt, G., Walker, A., Kabrun, N., Mellitzer, G., Beug, H , Zenke, M., and Enrietto, P. J. Hormone-regulated v-rel estrogen receptor fusion protein: reversible induction of cell transformation and cellular gene expression. EMBO J., 11: 4641-4652, 1992.
5. Jackson, P., Baltimore, D , and Picard, D. Hormone-conditional transformation by fusion proteins of c-Ab1 and its transforming variants. EMBO J., 12: 2809-2819, 1993
6. Samuels, M. L., Weber, M. J., Bishop, J. M., and McMahon, M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell Biol , 13: 6241-6252, 1993.
7. Picard, D., Salser, S. J., and Yamamoto, K. R. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell. 54: 1073-1080, 1988.
8. Hope, T. J., Huang, X., McDonald, D., and Parslow, T. G. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc. Natl. Acad. Sci. USA, 87: 7787-7791, 1990.
9. Umek, R. M., Friedman, A D., and McKnight, S. L. CCAAT-enhancer binding protein: a component of a differentiation switch. Science (Washington DC), 251: 288-292, 1991.
10. Braselmann, S., Graninger, P , and Busslinger, M. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci USA, 90: 1657-1661, 1993.
11. Hollenberg, S. M., Cheng, P. F., and Weintraub, H. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. Proc. Natl. Acad. Sci. USA, 90: 8028-8032, 1993.
12. Briegel, K , Lim, K-C., Plank, C., Beug, H., Engel, J. D., and Zenke, M. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner Genes Dev., 7: 1097-1109, 1993
13. Nakabeppu, Y., Oda, S , and Sekiguchi, M. Proliferative activation of quiescent Rat-1A cells by ΔFosB Mol. Cell. Biol , 13: 4157-4166, 1993.
14. Reichmann, E., Schwarz, H., Deiner, E. M , Leimer, I., Eilers, M., Berger, J., Busslinger, M., and Beug, H. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell. 71: 1103-1116, 1992.
15. Kakizuka, A., Miller, W. H . Jr., Umesono, K., Warrell, R. P., Jr., Frankel, S. R , Murty, V. V. V. S , Dmitrovsky, E., and Evans, R M. Chromosomal translocation t(15,17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML. Cell. 66: 663-674, 1991
16. Dyck, J. A., Maul, G G., Miller, W. H., Jr , Chen, J. D., Kakizuka, A., and Evans, R M A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell, 76 333-343, 1994.
17. Miller, W. H , Jr., Kakizuka, A., Frankel, S. R., Warrell, R. P., Jr, DeBlasio, A , Levine, K , Evans, R. M., and Dmitrovsky, E Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA, 89: 2694-2698, 1992.
18. Itoh, N , Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S-I , Sameshima, M , 4 Hase, A., Seto, Y., and Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell, 66: 233-243, 1991,
19. Yonehara, S., Ishu, A., and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169: 1747-1756, 1989
20. Trauth, B. C., Klas, C., Peters, A. M. J., Malzku, S., Moller, P. Falk, W , Debatin, K-M , and Krammer, P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Washington DC), 245: 301-305, 1989
21. Dhem, J , Daniel, P. T., Trauth, B C., Oehm, A., Moller, P., and Krammer, P. H. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens J. Immuol., 149: 3166-3173, 1992.
22. Tartaglia, I. A , Ayres, T. M., Wong, G. H. W., and Goeddel, D V. A novel domain within the 55 kd TNF receptor signals cell death. Cell, 74: 845-853, 1993.
23. Itoh, N., and Nagata, S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem., 268: 10932-10937, 1993
24. Sambrook, J , Fritsch, E. F., and Mantatis, T. Molecular Cloning: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
25. Watanabe-Fukunaga, R , Brannan, C. I , Itoh, N. Yonehara, S., Copeland, N G., Jenkins, N. A., and Nagata, S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol., 148, 1274-1279, 1992.
26. Inoue, J., Kerr, L. D., Kakizuka, A., and Verma, I. M. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB. a new member of the IkB family Cell, 68: 1109-1120, 1992.
27. Koike, S., Sakai, M., and Muramatsu, M. Molecular cloning and characterization of rat estrogen receptor cDNA Nucleic Acids Res., 15: 2499-2513, 1987.
28. Giguere, V., Ong, E. S , Segui, P., and Evans, R. M. Identification of a receptor for the morphogen retinoic acid. Nature (Lond.), 330: 624-629, 1987.
29. Petkovich, M., Brand, N. J , Krust, A., and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.), 330: 444-450, 1987.
30. Koelle, M R , Talbot, W. S., Segraves, W. A., Bender, M. T., Cherbas, P , and Hogness, D. S. The Drosophila EcR gene encodes an ecdysone receptor, a new member of the steroid receptor superfamily Cell, 67: 59-77, 1991.
31. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res., 15: 8125-8148, 1987.
32. Izumi, M., Miyazawa, H , Kamakura, T., Yamaguchi, I., Endo, T., and Hanaoka, F. Blasticidin S-resistance gene (bsr) a novel selectable marker for mammalian cells. Exp. Cell Res , 197: 229-233, 1991.
33. Mizushima, S , and Nagata, S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res , 18: 5322, 1990.
34. Molloy, C. J., Bottaro, D. P., Fleming, T. P., Marshall, M S., Gibbs, J B., and Aaronson, S A. PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature (Lond.), 342: 711-714, 1989.
35. Nakai, A., Kawatani, T., Ohi, S., Kawasaki, H., Yoshimori, T., Tashiro, Y., Miyata, Y , Yahara, I., Satoh, M., and Nagata, K. Expression and phosphorylation of BiP/ GRP78, a molecular chaperone in the endoplasmic reticulum, during the differentiation of a mouse myeloblastic cell line Cell Struct. Funct., 20. 33-39, 1995.
36. Kakizuka, A , Kitamura, N., and Nakanishi, S. Localization of DNA sequences governing alternative mRNA production of rat kininogen genes. J. Biol. Chem., 263: 3884-3892, 1988.
37. Kakizuka, A., Ingi, T., Murai, T , and Nakanishi, S A set of U1 snRNA-complementary sequences involved in governing alternative RNA splicing of the kininogen u genes. J. Biol. Chem., 265: 10102-10108, 1990.
38. Sun, L , Wu, G , Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J , Gentry, L. E , Wang, X-F., and Brattam, M G. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem , 269: 26449-26455, 1994.
39. Claus, S., Aumüller, G., Tunn, S., Senge, T., and Schulze, H. Influence of hormone application by subcutaneous injections or steroid-containing silastic implants on human benign hyperplastic prostate tissue transplanted into male nude mice. Prostate, 22: 199-215, 1993.
40. Chomczynski, P , and Sacchi, N Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem , 162: 156-159, 1987
41. Kakizuka, A , Sebastian, B., Borgmeyer, U. Hermans-Borgmeyer, I., Bolado, J , Hunter, T , Hoekstra, M. F , and Evans, R. M A mouse cdc25 homolog is differentially and developmentally expressed. Genes Dev., 6: 578-590, 1992.
42. Ishida, Y., Agata, Y , Shibahara, K., and Honjo, T. Induced expression of PD-1, a novel member of the immimoglobulin gene superfamily, upon programmed cell death. EMBO J., 11 3887-3895, 1992
43. Gavrieh, Y., Sherman, Y., and Ben-Sasson, S. A Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol., 119-493-501, 1992
44. Katzung, B. G Basic & Clinical Pharmacology, p 624. Norwalk, CT: Appleton & Lange, 1995
45. Field, J , Nikawa, J , Broek, D., MacDonald, B., Rodgers, L , Wilson, I. A., Lerner, R. A., and Wigler, M Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method Mol. Cell. Biol., 8. 2159-2165, 1988.
46. Sato, T., Irie, S., Kitada, S., and Reed, J. C FAP-1: a protein tyrosine phosphatase that associates with Fas. Science (Washington DC), 268: 411-415, 1995.
47. Berry, M , Metzger, D , and Chambon, P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen EMBO J , 9: 2811-2818, 1990
48. Korach, K., Fox-Davies, C., and Baker, V. Differential response to estriol and estradiol in the mouse uterus correlation to an additional nuclear event. Endocrinology, 106: 1900-1906, 1980.
49. Wakeling, A. E., and Bowler, J. Novel antioestrogens without partial agonist activity. J Steroid Biochem., 31: 645-653, 1988.
50. No, D., Yao, T-P., and Evans, R M Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl. Acad. Sci. USA, 93: 3346-3351, 1996
51. Yao, T-P., Segraves, W. A., Oro, A. E , McKeown, M., and Evans, R. M. Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell, 71: 63-72, 1992
52. Yao, T-P., Forman, B. M., Jiang, Z., Cherbas, L , Chen, J-D., McKeown, M., Cherbas, P., and Evans, R. M. Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature (Lond.), 366: 476-479, 1993.
53. Block, T., Brzykcy, J., Hastie, N., and Hughes, R. G , Jr. Genetic linkage but independent expression of functional HSV-1 tk and mammalian aprt genes after cotransfer to L cells. Can. J Microbiol., 31: 311-316, 1985.
54. Bergman, M. D., Schachter, B. S., Karelus, K., Combatsiaris, E. P., Garcia, T., and Nelson, J. F. Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle, the role of estradiol. Endocrinology, 130: 1923-1930, 1992
55. Bradlow, H. L. Steroid-protein interactions: the first fifty years. Ann. NY Acad Sci , 538: 3-9, 1988.
56. Muindi, J., Frankel, S R., Miller, W. H , Jr., Jakubowski, A , Scheinberg, D. A , Young, C. W., Dmitrovsky, E., and Warrell, R P., Jr Continuous treatment with all-trans retinose acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood. 79: 299-303, 1992.
57. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H-J., Broger, C., Loetscher, H., and Lesslauer, W Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell, 73: 431-445, 1993.
58. Mangelsdorf, D. J , Thummel, C., Beato, M., Herrlich, P., Schütz, G , Umesono, K., Blumberg, B., Kasmer, P , Mark, M., Chambon, P., and Evans, R. M. The nuclear receptor superfamily: the second decade. Cell, 83: 835-839, 1995.
59. Song, H. Y., Dunbar, J. D , and Donner, D. B. Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. J Biol Chem., 269: 22492-22495, 1994.
60. Stokoe, D., Macdonald, S. G., Cadwallader, K , Symons, M., and Hancock, J F. Activation of Raf as a result of recruitment to the plasma membrane. Science (Washington DC), 264. 1463-1467, 1994.
61. Leavers, S. J., Paterson, H F., and Marshall, C. J. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane Nature (Lond.), 369: 411-414, 1994.
62. Hsu, H , Xiong, J., and Goeddel, D V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell, 81: 495-504, 1995.
63. Chinnaiyan, A. M., O'Rourke, K , Tewari, M., and Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis Cell, 81: 505-512, 1995.
64. Stanger, B Z., Leder, P., Lee, T-H., Kim, E., and Seed, B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81 513-523, 1995.
65. Boldin, M. P., Goncharov, T M , Goltsev, Y. V., and Wallach, D. Involvement of MACH, a novel MOLT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell, 85. 803-815, 1996.
66. Muzio, M., Chinnaiyan, A. M., Kischkel, F C , O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M , Gentz, R , Mann, M., Krammer, P. H , Peter, M. E , and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.